Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight [Yahoo! Finance]
Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)
Last sol-gel technologies ltd. - ordinary shares earnings: 11/13 07:05 am
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/markets/ipos/company/solgel-technologies-ltd-1031585-84610
Company Research
Source: Yahoo! Finance
and typically characterized by slow growth and low metastatic potential. The increasing prevalence of skin cancers due to rising UV exposure and an aging population is driving demand for effective diagnostics and treatment options for basal cell neoplasms. Additionally, the launch of therapies such as Patidegib, AIV001, FLD-103, VP-315, Silmitasertib, RP1, SP-002, R 5780, STP705, BO-112, AVX001, and others will further drive the market. New York, USA, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight Basal Cell Neoplasms are the most common type of skin cancer, arising from basal cells in the epidermis and typically characterized by slow growth and low metastatic potential. The increasing prevalence of skin cancers due to rising UV exposure and an aging population is driving demand for effective diagnostics and treatment options for basal cell neoplasms. Addit
Show less
Read more
Impact Snapshot
Event Time:
SLGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLGL alerts
High impacting Sol-Gel Technologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SLGL
News
- Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Sol-Gel Technologies (NASDAQ:SLGL) had its "hold (c)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate UpdatesGlobeNewswire
- Insiders At Sol-Gel Technologies See Good Returns After Buying Stock Worth US$867.1k [Yahoo! Finance]Yahoo! Finance
- Sol-Gel Technologies (NASDAQ:SLGL) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=SLGL&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StMarketBeat
SLGL
Earnings
- 11/20/25 - Miss
SLGL
Sec Filings
- 12/3/25 - Form 4
- 11/26/25 - Form 4
- 11/21/25 - Form 4
- SLGL's page on the SEC website